Combat diseases of the aging brain
|Coordinator||Lunds universitet - Institutionen för kliniska vetenskaper, Lund|
|Funding from Vinnova||SEK 1 498 876|
|Project duration||November 2018 - July 2019|
Purpose and goal
The annual costs in Sweden associated with stroke, Alzheimer´s disease, and Parkinson´s disease is estimated to approximately 80 billion SEK. With the aging of the population, it is estimated that future costs will dramatically increase. To address the unmet medical need and societal challenge posed by these diseases, this project aims to build a dynamic innovative environment that will formulate a bold vision but realistic vision, achievable objectives, and sustainable action plan. The ultimate goal of the project is to reduce the burden of the diseases of the aging brain by 2030.
Expected results and effects
The immediate goal of this project is to build a strong national dynamic innovative environment based on the existing strengths of the partners and active interaction with stakeholders that will formulate a bold but realistic vision, achievable objectives, and sustainable action plan to reduce the burden of the diseases of the aging brain. Examples of the expected long-term effects are the development of new therapies and brain imaging technologies, and faster implementation of new preventive and therapeutic approaches into the health care system and society.
Planned approach and implementation
The project management together with existing and new partners will form a strong ecosystem of innovators from academia and health care, health care providers, and innovation companies, that will engage regulatory authorities, as well as politicians, decision makers, and patient organizations. The team will work through face-to-face as well as web-based discussions, meetings and workshops.